ENOB HB 01
Alternative Names: ENOB-HB-01; RENB-HB-01Latest Information Update: 21 Aug 2023
At a glance
- Originator G-Tech Bio
- Developer Renovaro Biosciences
- Class Antivirals; Gene therapies; RNA
- Mechanism of Action Apoptosis stimulants; Caspase 9 expression stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hepatitis B